Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,030 public trials 2,565 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study

NCT06751498

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital) Nanjing, Jiangsu, China
View Trial Details
Recruiting

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

NCT03592472

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University Of UA Cancer Center(UACC)/DH-SJHMC Phoenix, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCSF Helen Diller Family Comphrensive Cancer Center - Hemato San Francisco, California, United States
  • Norton Cancer Institute, Norton Healthcare Pavilion Louisville, Kentucky, United States
View all 38 locations
View Trial Details
Recruiting

Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr

NCT05421650

Conditions
Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • Aster CMI Hospital Bengaluru, India
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Italy
  • First Obstetrics and Gynecology Clinic, "G. E. Palade" University of Medicine, Pharmacy, Science and Technology Târgu Mureş, Romania
  • Soon Chun Hyang University Hospital Cheonan Cheonan, Chungcheongnam-do, South Korea
View all 26 locations
View Trial Details
Recruiting

First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer

NCT06502743

Conditions
Endometrial Cancer, Endometrial Carcinoma, Endometrial Neoplasms, +13 more
Locations
  • National Cancer Center Kyeonggi-do, South Korea
  • Severance hospital Seoul, South Korea
  • Korea University Guro Hospital Seoul, South Korea
  • Samsung Medical Center Seoul, South Korea
View Trial Details

Related conditions